Octagon Capital Advisors LP Allovir, Inc. Transaction History
Octagon Capital Advisors LP
- $433 Million
- Q2 2024
A detailed history of Octagon Capital Advisors LP transactions in Allovir, Inc. stock. As of the latest transaction made, Octagon Capital Advisors LP holds 9,800,000 shares of ALVR stock, worth $9.31 Million. This represents 1.63% of its overall portfolio holdings.
Number of Shares
9,800,000
Previous 4,200,000
133.33%
Holding current value
$9.31 Million
Previous $3.19 Million
121.05%
% of portfolio
1.63%
Previous 0.5%
Shares
2 transactions
Others Institutions Holding ALVR
# of Institutions
73Shares Held
46.5MCall Options Held
201KPut Options Held
3.1K-
Eco R1 Capital, LLC San Francisco, CA11.3MShares$10.7 Million0.29% of portfolio
-
Artal Group S.A. Luxembourg, N46.6MShares$6.27 Million0.3% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.3MShares$3.13 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.65MShares$2.51 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA1.91MShares$1.81 Million0.09% of portfolio
About Allovir, Inc.
- Ticker ALVR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,063,400
- Market Cap $88.4M
- Description
- Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...